arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Dianthus Therapeutics, Inc.

DNTH Health Care Biotechnology: Pharmaceutical Preparations
$80.51
▼ -4.3% Today
as of Jun 7, 07:13 ET
Last 30 days -3.78% Apr 28 → Jun 05
$79.51 $83.14 $86.76 $90.39 $94.01 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$84.03
High
$85.82
Low
$79.64
Volume
$835,881
Avg Vol
$717,546
Mkt Cap
$5.0B
P/E (TTM)
Beta
52w High
$96.50
52w Low
$16.64
Div Yield
Shares Out
$55M

Overview

52-week range
$17
$96
80% of range
Avg surprise (last 2)
+16.0%
Avg reaction (last 2)
+1.8%
100% positive
Latest IV / EM
66%
EM ±9.2% · $80 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-12.73$-9.68$-6.62$-3.56$-0.51 Actual $-12.73Actual $-3.78Actual $-0.54Actual $-0.51Actual $-0.74Actual $-0.82Est $-0.86Actual $-0.88Actual $-0.97Actual $-0.85Est $-1.17 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-41M$-30M$-19M$-8M$2M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.85 $-1.17 +27.4% -3.7% +1.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.97 financials
Mon Jun 30, 2025Jun 2025 $-0.88 financials
Mon May 12, 2025Mar/2025 $-0.82 $-0.86 +4.7% +2.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.74 financials
Sun Jun 30, 2024Jun 2024 $-0.51 financials
Sun Mar 31, 2024Mar 2024 $-0.54 financials
Sat Sep 30, 2023Sep 2023 $-3.78 financials
Fri Jun 30, 2023Jun 2023 $-12.73 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$396,000$193,000$1M$2M$2M
Cost of revenue
Gross profit
Operating income$-47M$-40M$-35M$-33M$-30M$-22M
Net income$-41M$-37M$-32M$-30M$-25M$-18M
EPS (diluted)$-0.85$-0.97$-0.88$-0.82$-0.74$-0.51

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$628M$51M$56M$13M$10M$23M$34M$314M
Inventory
Total current assets$1.12B$409M$414M$264M$271M$281M$287M$366M
Total assets$1.25B$531M$577M$326M$349M$374M$354M$369M
Long-term debt
Total liabilities$46M$38M$31M$23M$20M$22M$16M$11M
Total equity$1.20B$493M$546M$303M$329M$352M$338M$358M

Implied volatility — last 90 days

61%63%66%68%71% Jun 07 — IV 66% · EM ±9.2%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.